Most lately, it has been discovered that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger and isn't going to activate a 2nd messe